Neuroinflammation: The Silent Driver of Alzheimer’s Pathology

Neuroinflammation has increasingly been recognized as a major factor in Alzheimer’s disease progression. This session will explore how immune system dysfunction, particularly the role of microglia and astrocytes, contributes to neuroinflammation and the pathogenesis of dementia. It will examine how targeting neuroinflammation offers a potential therapeutic pathway for slowing or halting disease progression, with a focus on new anti-inflammatory therapies under development.
 

    Related Conference of Neuroinflammation: The Silent Driver of Alzheimer’s Pathology

    May 21-22, 2025

    7th European Autism Congress

    Paris, France
    June 16-17, 2025

    35th Euro Congress on Psychiatrists and Psychologists

    Frankfurt, Germany
    June 16-17, 2025

    10th International Conference on Addiction Therapy

    Zurich, Switzerland
    June 16-17, 2025

    3rd International Conference onPsychiatry and Psychology

    Zurich, Switzerland
    June 19-20, 2025

    5th Annual Congress on Mental Health

    Paris, France
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France

    Neuroinflammation: The Silent Driver of Alzheimer’s Pathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in